phase readout

NCT06768671: An Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolescents With Moderate to Severe Hidradenitis Suppurativa (VELA-TEEN)

ACTIVE_NOT_RECRUITINGupdated 1mo ago

community read0 votes

Sponsor: MoonLake Immunotherapeutics AG. Phase: PHASE3. Conditions: Hidradenitis Suppurativa

Data sources

last refreshed 1h ago

Found something off?

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?